CanceRNA global consortium looks to RNA-based immunotherapy

CanceRNA has been set up, a global consortium aiming to apply RNA-based therapeutics to successfully unlock anti-cancer immune responses. 

Related Keywords

Jerusalem , Israel General , Israel , Lisbon , Lisboa , Portugal , Brussels , Bruxelles Capitale , Belgium , Spain , Hebrew University , Yerushalayim , Amsterdam , Noord Holland , Netherlands , Barcelona , Comunidad Autonoma De Cataluna , Tanja Degruijl , Daniel Helman , Michal Lotem , Rotem Karni , Juan Valcarcel , Maria Carmo Fonseca , Regine Shevach , Seth Salpeter , Lynne Maquat , Evelien Smits , Erez Levanon , Pablo Menendez , Simon Geissler , Hadassah Medical School , University Of Lisbon , University Of Amsterdam , Jose Carreras Leukemia Institute , Niels Schaft Of The University Erlangen , Bar Ilan University , University Of Brussels , University Of Rochester , Hadassah University Medical Center , Hadassah Cancer Research Institute , Department Chair , Molecular Biology , Hebrew University Hadassah Medical School , Genomic Regulation , Niels Schaft ,